Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 17, 2023

BUY
$17.77 - $21.6 $178,375 - $216,820
10,038 New
10,038 $0
Q2 2022

Aug 01, 2022

SELL
$16.57 - $35.1 $134,515 - $284,941
-8,118 Closed
0 $0
Q1 2022

Apr 11, 2022

BUY
$31.92 - $47.45 $259,126 - $385,199
8,118 New
8,118 $261,000

Others Institutions Holding ITOS

About iTeos Therapeutics, Inc.


  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $257M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Maryland State Retirement & Pension System Portfolio

Follow Maryland State Retirement & Pension System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maryland State Retirement & Pension System, based on Form 13F filings with the SEC.

News

Stay updated on Maryland State Retirement & Pension System with notifications on news.